APL and CurifyLabs partner to support patients with 3D printing medicine technology

Critically ill individuals will benefit from futuristic tech

APL, one of Sweden’s largest manufacturers of extemporaneous medicines and a leading contract development and manufacturing organization (CDMO), has announced a partnership with CurifyLabs, a Finnish health tech company specializing in personalized medicine manufacturing solutions. This collaboration aims to enhance the administration of medicines to children and critically ill patients using innovative 3D printing technology.

3D printing offers significant advantages over traditional pharmaceutical processes by enabling the production of more personalized dosages and dosage forms with flexible shapes and structures. This technology allows for precise dosing, which can help reduce side effects.

Currently, APL’s manufacturing method produces at least 100 capsules per batch. However, with 3D printing technology, precise doses can be created, reducing waste and promoting sustainability. This automated approach also improves the working environment for staff by lowering the risk of repetitive strain injuries and limiting exposure to toxic substances.

Erik Haeffler, Chief Executive Officer at APL, stated, “We are very impressed with CurifyLabs’ commitment to supporting us on our journey to address the urgent unmet needs of critically ill patients. 3D printing is an exciting technology that is well-suited to extemporaneous manufacturing. It will give us additional opportunities to fulfill our public policy assignment.”

Charlotta Topelius, Chief Executive Officer at CurifyLabs, added, “APL has demonstrated its strong capabilities in extemporaneous medicines with high quality and consistency, which will be critical to accelerating our development efforts together. We look forward to combining our strengths to create even greater value for patients needing personalised medicines.”

APL expects to provide fully compliant and validated 3D-printed extemporaneous medicines to the Swedish market by 2025, with the first 3D printers to be delivered in September 2024.